The DOI matches its Crossref record; 67 of the 68 references it cites were found in a registry or an index.
The natural history of insulin secretory dysfunction and insulin resistance in the pathogenesis of type 2 diabetes mellitus
Open accessAbstract
The pathogenesis of type 2 diabetes involves abnormalities in insulin action, insulin secretion, and endogenous glucose output (EGO). However, the sequence with which these abnormalities develop and their relative contributions to the deterioration in glucose tolerance remain unclear in the absence of a detailed longitudinal study. We measured insulin action, insulin secretion, and EGO longitudinally in 17 Pima Indians, in whom glucose tolerance deteriorated from normal (NGT) to impaired (IGT) to diabetic over 5.1 +/- 1.4 years. Transition from NGT to IGT was associated with an increase in body weight, a decline in insulin-stimulated glucose disposal, and a decline in the acute insulin secretory response (AIR) to intravenous glucose, but no change in EGO. Progression from IGT to diabetes was accompanied by a further increase in body weight, further decreases in insulin-stimulated glucose disposal and AIR, and an increase in basal EGO. Thirty-one subjects who retained NGT over a similar period also gained weight, but their AIR increased with decreasing insulin-stimulated glucose disposal. Thus, defects in insulin secretion and insulin action occur early in the pathogenesis of diabetes. Intervention to prevent diabetes should target both abnormalities.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Insulin resistance and concurrent relative insulin deficiency and glucagon dysregulation underlie T2D pathophysiology.33–35”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [34]
Experimental — accuracy not yet measuredIn the citing paper
“These findings derived from cross-sectional data are supported by a longitudinal study in Pima Indians that has also shown the importance of accounting for the hyperbolic relationship between insulin sensitivity and insulin secretion and demonstrated the presence of impaired beta-cell function in those destined to progress to Type 2 diabetes [95].”
From The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of type 2 diabetes (2003) · cites this paper as [95]
In the citing paper
“Seventeen (35%) of these subjects progressed from NGT to IGT and then to diabetes during follow up.”
From The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of type 2 diabetes (2003) · cites this paper as [95]
In the citing paper
“Our finding of a hyperbolic relationship between insulin sensitivity and insulin secretion in healthy subjects has been confirmed in large cohorts of Danish [94] and Pima Indian subjects [95].”
From The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of type 2 diabetes (2003) · cites this paper as [95]
In the citing paper
“During follow up, insulin secretion declined progressively by 78% while insulin sensitivity decreased by only 14%.”
From The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of type 2 diabetes (2003) · cites this paper as [95]
In the citing paper
“Based on the UKPDS [18] and the longitudinal assessment in Pima Indians [95], the major reason for the decline in glucose tolerance seems to be a progressive loss of beta-cell function.”
From The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of type 2 diabetes (2003) · cites this paper as [95]
In the citing paper
“Further progressive deterioration of β-cell function accounts for the evolving natural history of the disease from impaired glucose tolerance to type 2 diabetes10,11.”
From Pathophysiology and treatment of type 2 diabetes: perspectives on the past, present, and future (2014) · cites this paper as [10]
In the citing paper
“Our results may help explain the aforementioned association between N3 lack and T2DM, as a loss in first-phase insulin secretion is both an early marker of T2DM and part of its pathogenesis (20).”
From Sleep architecture and glucose and insulin homeostasis in obese adolescents (2011) · cites this paper as [20]
In the citing paper
“IGT and T2DM ensue when beta cell function fails to compensate.”
From The Vasculature in Prediabetes (2018) · cites this paper as [16]
In the citing paper
“Insulin resistance precedes the development of hyperglycemia and T2DM and results in compensatory hyperinsulinemia.”
From The Vasculature in Prediabetes (2018) · cites this paper as [16]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Role of Insulin Resistance in Human Disease
Reaven, G. M. (1988) · Diabetes · doi:10.2337/diab.37.12.1595 · Cited by 12,154
Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance.
National Diabetes Data Group (1979) · Diabetes · doi:10.2337/diab.28.12.1039 · Cited by 4,909
Immunoassay of endogenous plasma insulin in man
Yalow, R. S., & Berson, S. A. (1960) · Journal of Clinical Investigation · doi:10.1172/jci104130 · Cited by 3,041
Coated Charcoal Immunoassay of Insulin
Herbert, V. D., Lau, K., Gottlieb, C. W., & Bleicher, S. J. (1965) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-25-10-1375 · Cited by 2,969
Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus
The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus (2003) · Diabetes Care · doi:10.2337/diacare.26.2007.s5 · Cited by 2,689
Body composition from fluid spaces and density: analysis of methods. 1961.
Siri, W. E. (1994) · PubMed · Cited by 2,556
The Triumvirate: β-Cell, Muscle, Liver: A Collusion Responsible for NIDDM
DeFronzo, R. A. (1988) · Diabetes · doi:10.2337/diab.37.6.667 · Cited by 2,456
Pathogenesis of NIDDM. A balanced overview.
DeFronzo, R. A., Bonadonna, R. C., & Ferrannini, E. (1992) · Diabetes Care · doi:10.2337/diacare.15.3.318 · Cited by 2,085
Bergman, R. N., Phillips, L. S., & Cobelli, C. (1981) · Journal of Clinical Investigation · doi:10.1172/jci110398 · Cited by 1,640 · cited 5×
“It is well known that there is a hyperbolic relationship between early insulin secretion and insulin action in individuals with NGT, meaning that, cross-sectionally, insulin secretion increases with decreasing insulin action and vice versa (51, 52).”
BackgroundMethodInfluentialTechniques for Measuring Body Composition
National Research Council (1961) · National Academies Press eBooks · doi:10.17226/21603 · Cited by 1,620
Research works printed but not linked: 6
- 1998, Diabetes Care, 21(Suppl. 1), S5
- DeFronzo, 1997, Diabetes Reviews, 5, 177
- Abbott, 1990, Am J Physiol, 258, E347
- Bogardus, 1984, J Clin Invest, 78, 1568
- Schwartz, 1995, J Clin Endocrinol Metab, 80, 1571
- Luzi, 1989, Am J Physiol, 257, E241
Cited by
Sorted by citations
Items 401–500 of 1,002
for the ACT NOW Study Group, DeFronzo, R. A., Banerji, M. A., Bray, G. A., Buchanan, T. A., Clément, S., Henry, R. R., Kitabchi, A. E., Mudaliar, S. R. D., Musi, N., et al. (2009) · Diabetologia · doi:10.1007/s00125-009-1614-2 · Cited by 74
Metabolic Effects of Obesity and Its Interaction with Endocrine Diseases
Clark, M., & Hoenig, M. E. (2016) · Veterinary Clinics of North America Small Animal Practice · doi:10.1016/j.cvsm.2016.04.004 · Cited by 74
Bonadonna, R. C., Stümvoll, M., Fritsche, A., Muggeo, M., Häring, H. U., Bonora, E., & van Haeften, T. W. (2003) · Diabetes · doi:10.2337/diabetes.52.2.470 · Cited by 74
Andreozzi, F., D’Alessandris, C., Federici, M., Laratta, E., Guerra, S. D., Prato, S. D., Marchetti, P., Lauro, R., Perticone, F., & Sesti, G. (2004) · Endocrinology · doi:10.1210/en.2003-0939 · Cited by 74
Diet-Induced Weight Loss Is Associated with an Improvement in β-Cell Function in Older Men
Utzschneider, K. M., Carr, D. B., Barsness, S. M., Kahn, S. E., & Schwartz, R. S. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031827 · Cited by 73
The RISE Consortium, Ehrmann, D. A., Temple, K. A., Rue, A., Barengolts, E., Mokhlesi, B., Van Cauter, E., Sam, S., Miller, M. A., Kahn, S. E., et al. (2019) · Diabetes Care · doi:10.2337/dc19-0556 · Cited by 73
The role of sulfonylureas in the treatment of type 2 diabetes
Tomlinson, B., Patil, N. G., Fok, M., Chan, P., & Lam, C. W. K. (2021) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2021.1999413 · Cited by 73
The Prevention of Type 2 Diabetes Mellitus
Inzucchi, S. E., & Sherwin, R. S. (2005) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2004.11.008 · Cited by 73
Bruin, J. E., Saber, N., Braun, N., Fox, J. K., Mojibian, M., Asadi, A., Drohan, C., O’Dwyer, S. M., Rosman-Balzer, D. S., Swiss, V. A., et al. (2015) · Stem Cell Reports · doi:10.1016/j.stemcr.2015.02.011 · Cited by 73
Effects of high-fat feeding and fasting on ghrelin expression in the mouse stomach
Moesgaard, S. G., Åhrén, B., Carr, R. D., Gram, D. X., Brand, C. L., & Sundler, F. (2004) · Regulatory Peptides · doi:10.1016/j.regpep.2004.03.018 · Cited by 73
The β Cell in Diabetes: Integrating Biomarkers With Functional Measures
Kahn, S. E., Chen, Y., Esser, N., Taylor, A. J., van Raalte, D. H., Zraika, S., & Verchere, C. B. (2021) · Endocrine Reviews · doi:10.1210/endrev/bnab021 · Cited by 75
Rivera-Mancía, S., Lozada-García, M. C., & Pedraza‐Chaverrí, J. (2015) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2015.02.045 · Cited by 72
Glucose Response Curve and Type 2 Diabetes Risk in Latino Adolescents
Kim, J. Y., Coletta, D. K., Mandarino, L. J., & Shaibi, G. Q. (2012) · Diabetes Care · doi:10.2337/dc11-2476 · Cited by 72
BACH2 inhibition reverses β cell failure in type 2 diabetes models
Son, J., Ding, H., Farb, T. B., Efanov, A. M., Sun, J., Gore, J. L., Syed, S. K., Lei, Z., Wang, Q., Accili, D., et al. (2021) · Journal of Clinical Investigation · doi:10.1172/jci153876 · Cited by 72
Chang, D. C., Xu, X., Ferrante, A. W., & Krakoff, J. A. (2019) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-019-0409-y · Cited by 71
Kim, B., Elzinga, S. E., Henn, R. E., McGinley, L. M., & Feldman, E. L. (2019) · Neurobiology of Disease · doi:10.1016/j.nbd.2019.104541 · Cited by 71
The Role of cAMP in Beta Cell Stimulus–Secretion and Intercellular Coupling
Stožer, A., Leitgeb, E. P., Pohorec, V., Dolenšek, J., Bombek, L. K., Gosak, M., & Klemen, M. S. (2021) · Cells · doi:10.3390/cells10071658 · Cited by 72
Wolever, T. M. S., Mehling, C. C., Chiasson, J. L., Josse, R. G., Leiter, L. A., Maheux, P., RABASA-LHORET, R. P. R., Rodger, N. W., & Ryan, E. A. (2008) · Diabetologia · doi:10.1007/s00125-008-1093-x · Cited by 71
Decrease in Glucose-Stimulated Insulin Secretion With Aging Is Independent of Insulin Action
Muzumdar, R. H., Ma, X., Atzmon, G., Vuguin, P. M., Yang, X., & Barzilai, N. (2004) · Diabetes · doi:10.2337/diabetes.53.2.441 · Cited by 71
β- and α-Cell Dysfunction in Subjects Developing Impaired Glucose Tolerance
Åhrén, B. (2008) · Diabetes · doi:10.2337/db08-1158 · Cited by 71
Liu, J., Chen, Z., Zhang, Y., Zhang, M., Zhu, X., Fan, Y., Shi, S., Zen, K., & Liu, Z. (2013) · Diabetes · doi:10.2337/db13-0251 · Cited by 72
Insulin‐like growth factors and pancreas beta cells
van Haeften, T. W., & Twickler, T. B. (2004) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2004.01337.x · Cited by 71
Sun, H., Temeck, J. W., Chambers, W., Perkins, G., Bonnel, R., & Murphy, D. (2018) · Therapeutic Innovation & Regulatory Science · doi:10.1177/2168479017725558 · Cited by 70
den Uyl, D., van Raalte, D. H., Nurmohamed, M. T., Lems, W. F., Bijlsma, J. W. J., Hoes, J. N., Dijkmans, B. A. C., & Diamant, M. (2012) · Arthritis & Rheumatism · doi:10.1002/art.33378 · Cited by 70
ACE2 deficiency reduces β-cell mass and impairs β-cell proliferation in obese C57BL/6 mice
Shoemaker, R., Yiannikouris, F. B., Thatcher, S. E., & Cassis, L. A. (2015) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00054.2015 · Cited by 70
Umpierrez, G. E., Gonzalez, A., Umpierrez, D., & Pimentel, D. (2007) · The American Journal of the Medical Sciences · doi:10.1097/maj.0b013e3180a6efe3 · Cited by 70
Marre, M., Gaal, L. V., Usadel, K., Ball, M., Whatmough, I., & Guitard, C. (2002) · Diabetes Obesity and Metabolism · doi:10.1046/j.1463-1326.2002.00196.x · Cited by 70
Weyer, C., DiStefano, J. K., Hanson, R. L., Foley, J. E., Tataranni, P. A., Bogardus, C., & Pratley, R. E. (2001) · Molecular Genetics and Metabolism · doi:10.1006/mgme.2001.3147 · Cited by 70
Self-citationCarr, D. B., Utzschneider, K. M., Boyko, E. J., Asberry, P. J., Hull, R. L., Kodama, K., Callahan, H. S., Matthys, C. C., Leonetti, D. L., Schwartz, R. S., et al. (2005) · Diabetes · doi:10.2337/diabetes.54.2.340 · Cited by 69
Liu, W., Li, Z., Feng, C., Hu, S., Yang, X., Xiao, K., Nong, Q.-N., Xiao, Q., Wu, K., Li, X., et al. (2021) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2021.119001 · Cited by 69
Yabe, D., Kuroe, A., Watanabe, K., Iwasaki, M., Hamasaki, A., Hamamoto, Y., Harada, N., Yamane, S., Lee, S., Murotani, K., et al. (2014) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2014.12.010 · Cited by 69
Koyanagi, M., Asahara, S., Matsuda, T., Hashimoto, N., Shigeyama, Y., Shibutani, Y., Kanno, A., Fuchita, M., Mikami, T., Hosooka, T., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0023238 · Cited by 69
Kihira, Y., Miyake, M., Hirata, M., Hoshina, Y., Kato, K., Shirakawa, H., Sakaue, H., Yamano, N., Izawa‐Ishizawa, Y., Ishizawa, K., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0093856 · Cited by 69
Type 2 Diabetes: When Does It Start?
Sagesaka, H., Sato, Y., Someya, Y., Tamura, Y., Shimodaira, M., Miyakoshi, T., Hirabayashi, K., Koike, H., Yamashita, K., Watada, H., et al. (2018) · Journal of the Endocrine Society · doi:10.1210/js.2018-00071 · Cited by 69
Gujral, U. P., Mohan, V., Pradeepa, R., Deepa, M., Anjana, R. M., & Narayan, K. M. V. (2018) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2018.09.011 · Cited by 69
In Vitro and In Vivo Antidiabetic Potential of Monoterpenoids: An Update
Kury, L. T. A., Abdoh, A., Ikbariah, K., Sadek, B. S., & Mahgoub, M. (2021) · Molecules · doi:10.3390/molecules27010182 · Cited by 68
Ranjit Unnikrishnan, I., Shaw, J. E., Chan, J. C. N., Wild, S. H., Peters, A. L., Orrange, S., Roden, M., & Mohan, V. (2025) · Nature Reviews Disease Primers · doi:10.1038/s41572-025-00635-0 · Cited by 69
Dagogo-Jack, S. E., Edeoga, C., Ebenibo, S., Nyenwe, E. A., & Wan, J. Y. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-1077 · Cited by 68
CHILTON, R. J., Wyatt, J., Nandish, S., OLIVEROS, R. A., & Lujan, M. (2010) · The American Journal of Medicine · doi:10.1016/j.amjmed.2010.11.004 · Cited by 68
Autophagy: Emerging Therapeutic Target for Diabetic Nephropathy
Kume, S., Yamahara, K., Yasuda, M., Maegawa, H., & Koya, D. (2013) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2013.11.003 · Cited by 68
Regression from prediabetes to normal glucose regulation: State of the science
Sallar, A. S., & Dagogo-Jack, S. E. (2020) · Experimental Biology and Medicine · doi:10.1177/1535370220915644 · Cited by 68
Pharmacological Management of Type 2 Diabetes Mellitus: Rationale for Rational Use of Insulin
Chan, J. L., & Abrahamson, M. J. (2003) · Mayo Clinic Proceedings · doi:10.4065/78.4.459 · Cited by 68
Lamounier, R. N., Coimbra, C. N., White, P., Costal, F., de Oliveira, L. S., Giannella‐Neto, D., Kaestner, K. H., & Corrêa‐Giannella, M. L. (2013) · Diabetology & Metabolic Syndrome · doi:10.1186/1758-5996-5-1 · Cited by 67
Genetic and pharmacologic inhibition of ALDH1A3 as a treatment of β-cell failure
Son, J., Du, W. J., Esposito, M., Shariati, K., Ding, H., Kang, Y., & Accili, D. (2023) · Nature Communications · doi:10.1038/s41467-023-36315-4 · Cited by 67
Siwy, J., Zoja, C., Klein, J., Benigni, A., Mullen, W., Mayer, B., Mischak, H., Jankowski, J., Stevens, R., Vlahou, A., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0051334 · Cited by 67
Vettor, R., Granzotto, M., Stefani, D. D., Trevellin, E., Rossato, M., Farina, M. G., Milan, G., Pilon, C., Nigro, A., Federspil, G., et al. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-2680 · Cited by 67
Hasson, B. R., Apovian, C. M., & Istfan, N. W. (2015) · Current Obesity Reports · doi:10.1007/s13679-015-0150-2 · Cited by 67
Impaired early- but not late-phase insulin secretion in subjects with impaired fasting glucose
Kanat, M., Norton, L., Winnier, D., Jenkinson, C. P., DeFronzo, R. A., & Abdul-Ghani, M. A. (2011) · Acta Diabetologica · doi:10.1007/s00592-011-0285-x · Cited by 67
Glucose challenge test screening for prediabetes and undiagnosed diabetes
Phillips, L. S., Ziemer, D. C., Kolm, P., Weintraub, W. S., Vaccarino, V., Rhee, M. K., Chatterjee, R., Narayan, K. M. V., & Koch, D. D. (2009) · Diabetologia · doi:10.1007/s00125-009-1407-7 · Cited by 67
Sobngwi, E., Enoru, S. T., Ashuntantang, G., Azabji‐Kenfack, M., Dehayem, M. Y., Onana, A., Biwole, D. B., Kaze, F., Gautier, J., & Mbanya, J. C. (2010) · Diabetes Care · doi:10.2337/dc09-2176 · Cited by 66
Chang, A. M., Smith, M. J., Bloem, C. J., Gałecki, A. T., Halter, J. B., & Supiano, M. A. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-1803 · Cited by 66
Tan, S. M. Q., Chiew, Y., Ahmad, B., & Kadir, K. A. (2018) · Nutrients · doi:10.3390/nu10091315 · Cited by 65
Diabetic eye disease: A review of screening and management recommendations
Gale, M. J., Scruggs, B. A., & Flaxel, C. J. (2021) · Clinical and Experimental Ophthalmology · doi:10.1111/ceo.13894 · Cited by 65
Anti-inflammatory effects of grape seed procyanidin B2 on a diabetic pancreas
Yin, W., Li, B., Li, X., Yu, F., Cai, Q., Zhang, Z., Cheng, M., & Gao, H. (2015) · Food & Function · doi:10.1039/c5fo00496a · Cited by 65
Type 2 diabetes, cardiovascular risk, and the link to insulin resistance
STOLAR, M. W., & CHILTON, R. J. (2003) · Clinical Therapeutics · doi:10.1016/s0149-2918(03)80240-0 · Cited by 65
Decreased β-Cell Function in Overweight Latino Children With Impaired Fasting Glucose
Weigensberg, M. J., Ball, G. D. C., Shaibi, G. Q., Cruz, M. L., & Goran, M. I. (2005) · Diabetes Care · doi:10.2337/diacare.28.10.2519 · Cited by 65
Snehalatha, C., Mary, S., Selvam, S., Sathish Kumar, C. K., Shetty, S. B. A., Nanditha, A., & Ramachandran, A. (2009) · Diabetes Care · doi:10.2337/dc09-0676 · Cited by 64
Activation of SIRT1 protects pancreatic β-cells against palmitate-induced dysfunction
Wu, L., Zhou, L., Lü, Y., Zhang, J., Jian, F., Liu, Y., Li, F., Li, W., Wang, X. Q., & Guo, L. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2012.08.009 · Cited by 64
Obesity and Insulin Resistance: An Abridged Molecular Correlation
Mukherjee, B., Hossain, C. M., Mondal, L., Paul, P., & Ghosh, M. K. (2013) · Lipid Insights · doi:10.4137/lpi.s10805 · Cited by 64
Insulin resistance in the liver: Deficiency or excess of insulin?
Bazotte, R. B., Silva, L. G., & Schiavon, F. P. M. (2014) · Cell Cycle · doi:10.4161/15384101.2014.947750 · Cited by 64
Fate of the beta-cell in the pathophysiology of type 2 diabetes
Campbell, R. K. (2009) · Journal of the American Pharmacists Association · doi:10.1331/japha.2009.09076 · Cited by 64
Yaturu, S. (2011) · Journal of Diabetes Mellitus · doi:10.4236/jdm.2011.14012 · Cited by 64
Pathogenesis and prediction of diabetes mellitus: lessons from integrative physiology.
Bergman, R. N. (2002) · PubMed · Cited by 64
Exenatide: a GLP-1 receptor agonist as novel therapy for Type 2 diabetes mellitus
Briones, M., & Bajaj, M. (2006) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.7.8.1055 · Cited by 63
Yang, X., Zhou, J., Shao, H., Huang, B., Kang, X., Wu, R., Bian, F., Hu, M., & Liu, D. (2022) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgac661 · Cited by 66
Worede, A., Alemu, S., Gelaw, Y. A., & Abebe, M. (2017) · BMC Research Notes · doi:10.1186/s13104-017-2571-3 · Cited by 63
van Raalte, D. H., & Verchere, C. B. (2017) · Diabetes Obesity and Metabolism · doi:10.1111/dom.12935 · Cited by 63
Cho, H., Kumar, S., Yang, D., Vaidyanathan, S. R., Woo, K., Garcia, I., Shue, H. J., Yoon, Y.-Z., Ferreri, K., & Choo, H. (2018) · ACS Sensors · doi:10.1021/acssensors.7b00864 · Cited by 63
Novel approaches to restore beta cell function in prediabetes and type 2 diabetes
Salunkhe, V. A., Veluthakal, R., Kahn, S. E., & Thurmond, D. C. (2018) · Diabetologia · doi:10.1007/s00125-018-4658-3 · Cited by 63
Hjelmesaeth, J. S., Hagen, M., Hartmann, A., Midtvedt, K., Egeland, T., & Jenssen, T. G. (2002) · Clinical Transplantation · doi:10.1034/j.1399-0012.2002.02059.x · Cited by 63
β-Cell rejuvenation with thiazolidinediones
Bell, D. S. H. (2003) · The American Journal of Medicine · doi:10.1016/j.amjmed.2003.08.010 · Cited by 63
Prevention and Treatment of Type 2 Diabetes in Youth
Libman, I. M., & Arslanian, S. A. (2006) · Hormone Research in Paediatrics · doi:10.1159/000095981 · Cited by 62
The Association between Serum Uric Acid and Residualβ-Cell Function in Type 2 Diabetes
Tang, W., Fu, Q., Zhang, Q., Sun, M., Gao, Y. J., Liu, X., Li, Q., Shan, S., & Yang, T. (2014) · Journal of Diabetes Research · doi:10.1155/2014/709691 · Cited by 62
Goals of Treatment for Type 2 Diabetes
Marchetti, P., Lupi, R., Guerra, S. D., Bugliani, M., D’Aleo, V., Occhipinti, M., Boggi, U., Marselli, L., & Masini, M. (2009) · Diabetes Care · doi:10.2337/dc09-s306 · Cited by 62
Mechanisms of β‐cell functional adaptation to changes in workload
Wortham, M., & Sander, M. (2016) · Diabetes Obesity and Metabolism · doi:10.1111/dom.12729 · Cited by 62
Psammomys Obesus, a Model for Environment-Gene Interactions in Type 2 Diabetes
Kaiser, N., Nesher, R., Donath, M. Y., Fraenkel, M., Behar, V., Magnan, C., Ktorza, A., Cerasi, E., & Leibowitz, G. (2005) · Diabetes · doi:10.2337/diabetes.54.suppl_2.s137 · Cited by 62
Perspective: The Search for Genes for Type 2 Diabetes in the Post-Genome Era
Elbein, S. C. (2002) · Endocrinology · doi:10.1210/endo.143.6.8831 · Cited by 62
Association between renin and atherosclerotic burden in subjects with and without type 2 diabetes
Gonçalves, I., Edsfeldt, A., Colhoun, H. M., Shore, A. C., Palombo, C., Natali, A., Fredrikson, G. N., Björkbacka, H., Wigren, M., Bengtsson, E., et al. (2016) · BMC Cardiovascular Disorders · doi:10.1186/s12872-016-0346-8 · Cited by 61
Petrie, J. R., Pearson, E. R., & Sutherland, C. D. (2010) · Biochemical Pharmacology · doi:10.1016/j.bcp.2010.11.010 · Cited by 61
Kendall, D. M., Cuddihy, R. M., & Bergenstal, R. M. (2009) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2009.05.009 · Cited by 62
Zhang, Y., Lu, X., Hong, J., Chao, M., Gu, W., Wang, W., & Ning, G. (2010) · Endocrine · doi:10.1007/s12020-010-9369-6 · Cited by 61
Koivula, R. W., Heggie, A. J., Barnett, A. L., Cederberg, H., Hansen, T. H., Koopman, A. D. M., Ridderstråle, M., Rutters, F., Vestergaard, H., Gupta, R., et al. (2014) · Diabetologia · doi:10.1007/s00125-014-3216-x · Cited by 61
Maiztegui, B., Borelli, M. I., Raschia, M. A., Zotto, H. H. D., & Gagliardino, J. J. (2008) · Journal of Endocrinology · doi:10.1677/joe-08-0386 · Cited by 61
Lee, Y. H., Tokraks, S., Pratley, R. E., Bogardus, C., & Permana, P. A. (2003) · Diabetologia · doi:10.1007/s00125-003-1226-1 · Cited by 61
Self-citationLee, E., Ryu, G. R., Ko, S., Ahn, Y., & Song, K. (2017) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2017.02.082 · Cited by 61
Tikellis, C., Cooper, M. E., & Thomas, M. C. (2005) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2005.08.007 · Cited by 61
Genetic and biochemical pathways of β‐cell failure in type 2 diabetes
Talchai, S. C., Lin, H. V., Kitamura, T., & Accili, D. (2009) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2009.01115.x · Cited by 60
Lee, E., Ryu, G. R., Ko, S., Ahn, Y., Yoon, K., Ha, H., & Song, K. (2011) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2011.09.087 · Cited by 60
Pathophysiology of type 2 diabetes mellitus in youth: the evolving chameleon
Tfayli, H. M., & Arslanian, S. A. (2009) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/s0004-27302009000200008 · Cited by 59
Zinc as a Potential Coadjuvant in Therapy for Type 2 Diabetes
Manuel Ruz, O., Fernando Carrasco, N., Rojas, P., Codoceo, J., Inostroza, J., Basfi-fer, K., Valencia, A., Vásquez, K. Y., Galgani, J. E., Pérez, Á., et al. (2013) · Food and Nutrition Bulletin · doi:10.1177/156482651303400210 · Cited by 59
Gu, W., Li, X., Liu, C., Yang, J., Ye, L., Tang, J., Gu, Y., Yang, Y., Hong, J., Zhang, Y., et al. (2006) · Endocrine · doi:10.1385/endo:30:2:217 · Cited by 58
Göke, B. (2008) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2007.01686.x · Cited by 58
Insulin Resistance and Hyperinsulinemia: the Egg and the Chicken
Abdul‐Ghani, M. A., & DeFronzo, R. A. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa364 · Cited by 58
Rajas, F., Labrune, P., & Mithieux, G. (2013) · Diabetes & Metabolism · doi:10.1016/j.diabet.2013.03.002 · Cited by 58
Pathogenesis of Type 2 Diabetes
Stümvoll, M., Goldstein, B. J., & van Haeften, T. W. (2007) · Endocrine Research · doi:10.1080/07435800701743810 · Cited by 58
Clinical and laboratory data of a large series of patients with congenital generalized lipodystrophy
Lima, J. G., Nóbrega, L. H. C., de Lima, N. N., Santos, M. G. D. N., Baracho, M. D. F. P., & Jerônimo, S. M. B. (2016) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-016-0140-x · Cited by 58
Gelidium elegans Extract Ameliorates Type 2 Diabetes via Regulation of MAPK and PI3K/Akt Signaling
Choi, J., Kim, K., Koh, E., & Lee, B.-Y. (2018) · Nutrients · doi:10.3390/nu10010051 · Cited by 58
Cheung, N. W., & Helmink, D. (2005) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2005.05.001 · Cited by 58
Identification of Quantitative Trait Loci for Glucose Homeostasis
Rich, S. S., Bowden, D. W., Haffner, S. M., Norris, J. M., Saad, M. F., Mitchell, B. D., Rotter, J. I., Langefeld, C. D., Wagenknecht, L. E., & Bergman, R. N. (2004) · Diabetes · doi:10.2337/diabetes.53.7.1866 · Cited by 58
Li, S., Feng, X., Hao, X., Zhu, Y., Zou, L., Chen, X., & Yao, Y. (2023) · Comprehensive Reviews in Food Science and Food Safety · doi:10.1111/1541-4337.13183 · Cited by 57
Metadata
- Authors
- Weyer, C., Bogardus, C., Mott, D. M., & Pratley, R. E.
- Affiliations
- National Institutes of Health (US)
- Corresponding author
- Weyer, Christian
- Venue
- Journal of Clinical Investigation
- Published
- 1999-09-15
- Volume
- 104
- Issue
- 6
- Pages
- 787-794
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC408438
- OpenAlex
- W2077149049
- Cited by
- 1,940
- References
- 68
- Citations by year
- 2026: 24 · 2025: 53 · 2024: 53 · 2023: 74 · 2022: 63 · 2021: 80 · 2020: 64 · 2019: 64 · 2018: 61 · 2017: 72 · 2016: 88 · 2015: 81 · 2014: 91 · 2013: 85 · 2012: 83
- FWCI
- 44.54
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Keywords
- type 2 diabetes, insulin resistance, insulin secretion, impaired glucose tolerance, Pima Indians, insulin-stimulated glucose disposal, weight gain, diabetes prevention, pathogenesis
- MeSH terms
- Insulin Secretion, Adult, Anthropometry, Diabetes Mellitus, Type 2, Female, Glucose, Glucose Tolerance Test, Humans, Insulin, Insulin Resistance, Male, Obesity, Sex Factors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
